首页> 美国卫生研究院文献>Journal of Clinical Biochemistry and Nutrition >Current Status of Herbal Drugs in India: An Overview
【2h】

Current Status of Herbal Drugs in India: An Overview

机译:印度草药的现状:概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Herbal drugs constitute a major share of all the officially recognised systems of health in India viz. Ayurveda, Yoga, Unani, Siddha, Homeopathy and Naturopathy, except Allopathy. More than 70% of India’s 1.1 billion population still use these non-allopathic systems of medicine. Currently, there is no separate category of herbal drugs or dietary supplements, as per the Indian Drugs Act. However, there is a vast experiential-evidence base for many of the natural drugs. This offers immense opportunities for Observational Therapeutics and Reverse Pharmacology. Evidence-based herbals are widely used in the diverse systems and manufactured, as per the pharmacopoeial guidelines, by a well-organised industry. Significant basic and clinical research has been carried out on the medicinal plants and their formulations, with the state-of-the-art methods in a number of Institutes/Universities. There are some good examples. Indian medicinal plants also provide a rich source for antioxidants that are known to prevent/delay different diseased states. The antioxidant protection is observed at different levels. The medicinal plants also contain other beneficial compounds like ingredients for functional foods. Hence, the global knowledge about Ayurveda and Indian herbals will hopefully be enhanced by information on the evidence-base of these plants. This will yield rich dividends in the coming years.
机译:草药在印度所有正式认可的卫生系统中占主要份额。阿育吠陀,瑜伽,乌纳妮,悉达,顺势疗法和自然疗法,除同种疗法外。在印度11亿人口中,超过70%的人仍在使用这些无病疗法的医学系统。目前,根据《印度药品法》,没有单独类别的草药或膳食补充剂。但是,许多天然药物都有大量的经验证据基础。这为观察疗法和反向药理学提供了巨大的机会。循证草药被广泛用于各种系统,并按照药典指南由组织良好的行业生产。在许多研究所/大学中,已经通过最先进的方法对药用植物及其制剂进行了重要的基础和临床研究。有一些很好的例子。印度药用植物还提供了丰富的抗氧化剂来源,这些抗氧化剂可预防/延缓不同的疾病状态。观察到不同水平的抗氧化保护。药用植物还包含其他有益化合物,例如功能性食品成分。因此,有关这些植物的证据基础的信息有望增强有关印度草药和印度草药的全球知识。在未来几年中,这将产生丰厚的股息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号